![Richard Benarous](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Historique de carrière de Richard Benarous
Anciens postes connus de Richard Benarous
Sociétés | Poste | Début | Fin |
---|---|---|---|
CellVir SAS
![]() CellVir SAS Pharmaceuticals: OtherHealth Technology CellVir SAS develops anti-retrovirals based on novel therapeutics. Its research is focused on HIV disease. The company was founded by Richard Benarous, Richard Platford, Armand Frydman, E. Thomas Bader, and Jean Deregnaucourt on March 20, 2006 and is headquartered in Evry, France. | Directeur Technique/Scientifique/R&D | 20/03/2006 | 20/11/2009 |
Fondateur | 09/11/2009 | 04/06/2012 | |
Cytomics Pharmaceuticals SA
![]() Cytomics Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Cytomics Pharmaceuticals is a biopharmaceutical company dedicated to discovering and developing drugs that control the degradation of proteins, to treat major human diseases. The company was founded in April 2000 in collaboration with Dominique Thomas (Research Director at the Center for Molecular Genetics of the CNRS) and Richard Benarous (Director of the Department for Infectious Diseases 'at the Cochin Institute of Molecular Genetics), both specialists recognized by the ubiquitin-proteasome protein degradation. | Fondateur | 09/11/2009 | 10/10/2011 |
Corporate Officer/Principal | 01/04/2000 | 09/11/2009 | |
Massachusetts Institute of Technology | Corporate Officer/Principal | - | - |
Statistiques
Internationale
France | 3 |
Etats-Unis | 2 |
Opérationnelle
Founder | 2 |
Corporate Officer/Principal | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Sectorielle
Health Technology | 3 |
Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 2 |
---|---|
Cytomics Pharmaceuticals SA
![]() Cytomics Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Cytomics Pharmaceuticals is a biopharmaceutical company dedicated to discovering and developing drugs that control the degradation of proteins, to treat major human diseases. The company was founded in April 2000 in collaboration with Dominique Thomas (Research Director at the Center for Molecular Genetics of the CNRS) and Richard Benarous (Director of the Department for Infectious Diseases 'at the Cochin Institute of Molecular Genetics), both specialists recognized by the ubiquitin-proteasome protein degradation. | Health Technology |
CellVir SAS
![]() CellVir SAS Pharmaceuticals: OtherHealth Technology CellVir SAS develops anti-retrovirals based on novel therapeutics. Its research is focused on HIV disease. The company was founded by Richard Benarous, Richard Platford, Armand Frydman, E. Thomas Bader, and Jean Deregnaucourt on March 20, 2006 and is headquartered in Evry, France. | Health Technology |
- Bourse
- Insiders
- Richard Benarous
- Expérience